The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity

Infectious Agents and Cancer

Volumn 4, Issue 1, 2009, Pages

  Gonçalves, Maria Alice G ^a   Soares, Edson G ^a   Donadi, Eduardo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; STAINING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VIRUS DETECTION; VIRUS TYPING;

EID: 69849110008     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-4-11     Document Type: Article

References (41)

1. CD4 T cell count, viral load and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. M Cardillo R Hagan J Abadi MA Abadi, Cancer 2001 93 111 4 10.1002/cncr.9016 11309776 (Pubitemid 32322165)
2. Biologie des infections papillomavirus. II. Réponse immunitaire. I Greslin C Mougin E Seilles, Ann Biol Clin 1998 56 267 76
3. Analysis of interleukin 6 gene expression in cervical neoplasia using quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. E Tartour A Gey X Sastre-Garau C Pannetier V Mosseri P Kourilsky WH Fridman, Cancer Res 1994 54 6243 8 7954473
4. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of uterine cervix. W Al-Saleh SL Giannini N Jacobs M Moutschen J Doyen J Boniver P Delvenne, J Pathol 1998 184 283 90 10.1002/(SICI)1096-9896(199803)184:3<283::AID-PATH253. 0.CO;2-K 9614381
5. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. L Belec R Gherardi C Payan T Prazuck JE Malkin C Tevi-Benissan J Pillot, Cytokine 1995 7 568 74 10.1006/cyto.1995.0077 8580374
6. Cytokine expression in squamous intraepithelial lesions of the uterine cervix, implications for the generation of local immunosuppression. SL Giannini W Al-Saleh H Piron N Jacobs J Doyen J Boniver P Delvenne, Clin Exp Immunol 1998 113 183 9 10.1046/j.1365-2249.1998.00639.x 9717966 (Pubitemid 28352835)
7. Isolation and characterization of tumour-infiltrating lymphocytes from cervical carcinoma. CG Hilders L Ras JD van Eendenburg Y Nooyen GJ Fleuren, Int J Cancer 1994 57 805 13 10.1002/ijc.2910570608 8206676 (Pubitemid 24216816)
8. The host-tumor immune conflict: from immunosuppression to resistance and destrution. S Chouaib C Asselin-Paturel F Mami-Chouaib A Caignard JY Blay, Immunol Today 1997 18 493 7 10.1016/S0167-5699(97)01115-8 9357142 (Pubitemid 27441593)
9. Down-regulation of CD25 expression on activated tumor-infiltrating lymphocytes derived from human cervical carcinoma. BC Sheu RH Lin HN Ho SC Huang, Hum Immunol 1997 56 39 48 10.1016/S0198-8859(97)00111-0 9455492 (Pubitemid 28018598)
10. Reversed CD4/CD8 ratios of tumour-infiltrating lymphocytes correlate with disease progression in human cervical cancer. BC Sheu SM Hsu HN Ho RH Lin PL Torng SC Huang, Cancer 1999 86 1537 43 10.1002/(SICI)1097-0142(19991015)86: 8<1537::AID-CNCR213.0.CO;2-D 10526283
11. Anergy and apoptosis in CD8 cells from HIV-infected persons. DE Lewis DSN Tang A Aduoppong W Schober JR Rodgers, J Immunol 1994 153 412 20 7515928
12. CD8+ T cells and not CD4+ cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. J Vingerhoets L Kestens G Penne H De Vuyst M Vandenbruaene Y Pelgrom E Bosmans M De Boers A Kasran M Azuma R Colebunders JL Ceuppens G Vanham, Clin Exp Immunol 1997 107 440 7 10.1046/j.1365-2249.1997.d01-964.x 9067514
13. AK Abbas AH Lichtman JS Pober, Cellular and Molecular immunology Philadelphia, USA: WB Saunders company 2000
14. VAF Alves CE Bacchi J Vassallo editors, Manual de Imunohistoquí mica São Paulo: Sociedade Brasileira de Patologia 1999
15. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. F Mota N Rayment S Chong A Singer B Chain, Clin Exp Immunol 1999 116 33 40 10.1046/j.1365-2249.1999.00826.x 10209502 (Pubitemid 29170001)
16. Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. N Coleman MA Stanley, Int J Cancer 1994 56 314 9 10.1002/ijc.2910560303 8314316
17. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. TS Frank SM Svoboda-Newman ED Hsi, Diag Mol Pathol 1996 5 220 4 10.1097/00019606-199609000-00012 (Pubitemid 26326302)
18. Detection and typing of genital human papillomavirus. Y Ting MM Manos, PCR protocols: A Guide to Methods and Applications, Innis MA, Gelfand DH, Sninsky JJ, White TJ, 1990
19. The use of general primers in the polymerase chain reaction permits the detection of broad spectrum of human papillomavirus genotypes. PJ Snijders AJ van den Brule HF Schrijnemakers G Snow CJ Meijer JM Walboomers, J Gen Virol 1990 71 173 81 10.1099/0022-1317-71-1-173 2154534
20. Human papillomavirus is a necessary cause of invasive cancer worldwide. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah PJ Snijders J Peto CJ Meijer N Munoz, J Pathol 1999 189 12 9 10.1002/(SICI)1096-9896(199909)189: 1<12::AID-PATH4313.0.CO;2-F 10451482
21. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. RK Saiki DH Gelfand S Stoffel SJ Scharf R Higuchi GT Horn KB Mullis HA Erlich, Science 1988 239 487 91 10.1126/science.2448875 2448875
22. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. CJ Sanguinetti E Dias-Neto AJ Simpson, Biotechniques 1994 17 914 21 7840973
23. The host response to lesions induced by human papillomavirus. Vaccine against virally induced cancers. M Stanley N Coleman M Chamberst, Willey, Chichester. Ciba Foundation Symposium 1994 187 21 44 7796671
24. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. SL Giannini P Hubert J Doyen J Boniver P Delvenne, Int J Cancer 2002 97 654 9 10.1002/ijc.10084 11807793 (Pubitemid 34087806)
25. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection. MAG Gonçalves EG Soares APM Fernandes BAL Fonseca JSR Bettini RTS Simes EA Donadi, Eur J Obstet Gynecol 2004 114 221 7 10.1016/j.ejogrb.2003.10.026 (Pubitemid 38622086)
26. T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. RP Edwards K Kuykendall P Crowley-Nowick EE Partridge HM Shingleton J Mestecky, Cancer 1995 76 1411 5 10.1002/1097-0142(19951015)76:8<1411::AID-CNCR28207608173.0.CO;2-V 8620416
27. HIV+ patients have increased lymphocyte infiltrates in CIN lesions. MC Bell D Schmidt-Grimminger E Turbat-Herrera A Tucker L Harkins N Prentice PA Crowley-Nowick, Gynecol Oncol 2000 76 315 9 10.1006/gyno.1999.5716 10684703 (Pubitemid 30131500)
28. The cellular response associated with cervical intraepithelial neoplasia in HIV+ and HIV- subjects. SM Ahmed H Al WM Reid MA Johnson LW Poulter, Scand J Immunol 2002 56 204 211 10.1046/j.1365-3083.2002.01118.x 12121440 (Pubitemid 34779860)
29. Host immune responses to cervical cancer. S Patel S Chiplunkar, Curr Opin Obtet Gynecol 2009 21 54 9 10.1097/GCO.0b013e32831a9890
30. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia. HJ Bontkes TD De Gruijl AJC van den Muysenberg RH Verheijen MJ Stukart CJ Meijer RJ Scheper SN Stacey MF Duggan-Keen PL Stern S Man LK Borysiewicz JM Walboomers, Int J Cancer 2000 88 92 8 10.1002/1097- 0215(20001001)88:1<92::AID-IJC15>3.0.CO;2-E 10962445
31. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. LV Ronco AY Kapova M Vidal PM Howley, Genes Dev 1998 12 2061 72 10.1101/gad.12.13.2061 9649509
32. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Engelmayer M Larsson M Subklewe A Chahroudi WI Cox RM Steinman N Bhardwaj, J Immunol 1999 163 6762 8 10586075
33. Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition. P Finzer U Soto H Delius A Patzelt JF Coy A Poustka H zur Hausen F Rosl, Oncogene 2000 19 3235 44 10.1038/sj.onc.1203643 10918580
34. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. T Tsukui A Hildesheim MH Schiffman J Lucci 3rd D Contois P Lawler BB Rush AT Lorincz A Corrigan RD Burk W Qu MA Marshall D Mann M Carrington M Clerici GM Shearer DP Carbone DR Scott RA Houghten JA Berzofsky, Cancer Res 1996 56 3967 74 8752165
35. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. JC Luxton AJ Rowe JC Cridland T Coletart P Wilson PS Shepherd, J Gen Virol 1996 77 593 602 10.1099/0022-1317-77-7-1585 8627247
36. Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity. ME Ressing R Offringa RE Toes F Ossendorp JH de Jong RM Brandt WM Kast CJ Melief, Immunotechnology 1996 2 241 51 10.1016/S1380-2933(96)00057-7 9373306 (Pubitemid 27037858)
37. Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. TD De Gruijl HJ Bontkes JMM Walboomers MJ Stukart FS Doekhie AJ Remmink TJ Helmerhorst RH Verheijen MF Duggan-Keen PL Stern CJ Meijer RJ Scheper, Cancer Res 1998 58 1700 6 9563486
38. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. BC Sheu RH Lin HC Lien HN Ho SM Hsu SC Huang, J Immunol 2001 167 2972 8 11509647
39. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression. TE Reichert S Nagashima Y Kashii J Stanson G Gao QP Dou TL Whiteside, Oncogene 2000 19 514 25 10.1038/sj.onc.1203391 10698521
40. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. S Yasumura WC Lin E Weidmann P Hebda TL Whiteside, Int J Cancer 1994 15 225 234 10.1002/ijc.2910590215 (Pubitemid 24343367)
41. Immunophenotypic analysis of the transformation zone of human cervix. M Roncalli M Sideri P Gie E Servida, Lab Invest 1988 58 141 9 2448545